bottom line overweight rate reflect
view sale acceler sustain follow propos
acquisit ge biopharma expect close end
dhr result guidanc mix implic
result better expect report organ sale
growth exceed estim
out-performance broad-bas adj ep exceed
guide-start conserv model
growth expect previou
expect achiev year ep
 also sit prior reduc
higher accret ge biopharma achiev core growth
well ahead expect annual framework
increment growth along favor financ term partial
off-set divestitur prompt manag upsiz guidanc
year one earn accret
model updat roll result incorpor
manag guidanc updat view adjust
estim note
herein maintain overweight rate increas price
target
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
non-gaap ep exclud amort acquisition-rel intang asset
one time cost
compani data secur llc estim reuter
price target
price target reflect enterpris valu use project level debt cash includ
assumpt around ge biopharma contribut ebitda ex option
multipl premium life scienc tool diagnost high qualiti industri peer
group believ appropri given prospect faster earn growth downsid risk
overweight rate includ limit follow factor first given scale recent
deal flow acquisit target select integr risk stand potenti headwind investor
interest stori second signific global exposur lead risk neg impact global
macro deterior gener well china headwind specif final competit
pressur especi diagnost could weigh futur profit
overweight rate reflect view sale acceler sustain follow
propos acquisit expect close earli
washington dc-base corp nyse industri conglomer focus use
continu improv techniqu improv perform acquir busi compani
product typic distinguish strong brand name innov technolog major market
posit razor/razor-blad busi model compani oper four segment life scienc
diagnost dental environment appli life scienc segment sell mass spec
chromatographi filtrat microscopi centrifug flow cytometri product pharma academia
certain industri end market diagnost sell wide varieti diagnost test equip
hospit lab refer lab patholog lab point-of-car set dental sell orthodont
implant dispos tool larger equip dental offic environment appli divid
two piec water qualiti product identif
